AzTrials
AzTrials

Venous; Return (Anomaly)RPVINCT03572894

Comparison of PVI and RPVI

An observational study of Venous; Return (Anomaly), run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pleth Variability Index (PVI) is a non-invasive and automated measure of the respiratory variations of plethysmography during mechanical ventilation. PVI is extracted via an algorithm implemented on Masimo Radical 7 device (Masimo, Irvine, CA). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Venous; Return (Anomaly)
What is being tested?
PVI and RPVI measurements
Type of treatment
Medical device
How many people
35 participants
Where
1 siteFrance
Study dates
25 Jul 2018to 27 Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: All adult patients undergoing closed-chest surgery in the supine position under general anaesthesia.

Who may be able to join

  • Age > 18
  • Low or intermediate risk surgery or noninvasive procedures in the supine position
  • General anaesthesia and volume-controlled mechanical ventilation.

Who cannot join

  • Non sinus heart rhythm
  • Left Ventricular Ejection Fraction < 50%
  • Documented right ventricle failure
  • Lack of patient consent
  • Pregnancy
  • Minor patient or under tutorship
Show all 11Show fewer
  • Presence of spontaneous ventilatory movements (attested by a real respiratory rate higher than the set respiratory rate)
  • Report HR / RR <3.6 (HR: heart rate, RR: respiratory rate)
  • Open chest surgery
  • Laparoscopic surgery
  • Vital or lateral decubitus surgery

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service d'Anesthésie Réanimation, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon

    Bron, 69394

Other trials in France

About this study

Official title: Comparison of PVI and RPVI During a Tidal Volume Challenge Under General Anesthesia: A Prospective Validation Pilot Study

Pleth Variability Index (PVI) is a non-invasive and automated measure of the respiratory variations of plethysmography during mechanical ventilation. PVI is extracted via an algorithm implemented on Masimo Radical 7 device (Masimo, Irvine, CA). PVI is commonly used in anesthesiology and has been validated to predict fluid responsiveness and optimize fluid administration in the surgical setting. However, the signal/noise ratio of PVI makes acute changes in PVI somewhat difficult to interpret at the bedside. Subsequently, a new algorithm entitled RPVI (Rainbow Pleth Variability Index), has been developed in order to improve the signal/noise ratio of PVI and facilitate its clinical use by practitioners. The details of this new proprietary built-in algorithm are unknown and no data are available to date. Therefore, the main objective of the study was to compare RPVI and PVI during dynamic changes in venous return induced by a tidal volume (Vt) challenge during mechanical ventilation in anesthetized patients. The hypothesis was that the agreement between both dynamic indices would be good.

Being tested
PVI and RPVI measurements
Medical subject headings
Congenital Abnormalities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PVI and RPVI measurementsDevice

    PVI and RPVI measurements during variations of the tidal volume (Vt challenge) and a recruitment maneuver in anesthetized and mechanically ventilated patients.

    • T0 : Vt 6 mL/kg of predicted body weight (PBW) during 5 minutes
    • T1 : Vt 8 mL/Kg of PBW during 5 minutes
    • T2 : Vt 10 mL/kg of PBW during 5 minutes
    • T3 : Vt 6 mL/kg of PBW during 5 minutes
    • T4 : A single recruitment maneuver

    Data will be recorded at each step.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the diagnostic characteristics of RPVI in comparison to PVI

    Agreement and interchangeability of RPVI and PVI: Bland Altman analysis for repeated measurements

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2018
  2. Study start25 Jul 2018
  3. Primary completion27 Sep 2018
  4. Study completion27 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03572894
Sponsor's protocol ID
69HCL18_0313
Acronym
RPVI
Status last verified
Jun 2018
First submitted
19 Jun 2018
Last updated
5 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Venous; Return (Anomaly), run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the diagnostic characteristics of RPVI in comparison to PVI (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in